MKC
Get informed when a big investor buys or sells
+ FollowJune 27, 2024 - AI Summary
Undervalued by 23.2% based on the discounted cash flow analysis.
| Market cap | $12.74 Billion |
|---|---|
| Enterprise Value | $17.47 Billion |
| Dividend Yield | $1.92 (3.93%) |
| Earnings per Share | $2.94 |
| Beta | 0.67 |
| Outstanding Shares | 268,800,000 |
| P/E Ratio | 7.75 |
|---|---|
| PEG | 1.47 |
| Price to Sales | 1.78 |
| Price to Book Ratio | 1.65 |
| Enterprise Value to Revenue | 2.46 |
| Enterprise Value to EBIT | 16.48 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 0.7 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.2584▼ 8.17% |
|---|---|
| Total Calls | 1,258,700▲ 25.21% |
| Total Puts | 1,584,000▲ 17.58% |
Holdings and activity of institutional investors.
| Ownership % | 85.54%▼ 0.98% |
|---|---|
| Total Invested | $11.55B▼ 27.02% |
| Investors Holding | 975▼ 41.00% |
No data
Provides official revenue estimates and technical expertise for tax legislation, directly influencing corporate tax structures and the overall tax burden on McCormick.
Controls taxation and trade policy (tariffs, agreements), directly impacting McCormick's corporate tax burden and the cost/availability of imported ingredients and market access for exports.
Oversees the Farm Bill and agricultural policies, directly impacting the cost and availability of raw materials (spices, ingredients) for McCormick.
Regulates the FDA, which directly oversees food safety and labeling for McCormick's products, and influences labor laws impacting its workforce.